Advances in drug delivery: Less is more

The world of perioperative medications associated with cataract surgery for the premium surgeon is evolving rapidly.
We have gone from the days of finally having a topical NSAID eye drop to now having it as a once-daily brominated formulation with greater potency (Prolensa, Bausch + Lomb; BromSite, Sun Pharmaceuticals), from the days of finally having an ester topical steroid (Lotemax suspension, Bausch + Lomb) to now having submicron- and nano-formulations of the same with greater aqueous penetration (Lotemax SM, Bausch + Lomb; Inveltys, Kala), from the days of hourly topical (Read more...)

Full Story →